, , ,
doi.org/10.1093/annonc/mdg491, hdl.handle.net/1765/71024
Annals of Oncology
Department of Neurology

van den Bent, M., Grisold, W., Frappaz, D., Stupp, R., Desir, J. P., Lesimple, T., … Fumoleau, P. (2003). European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. Annals of Oncology, 14(12), 1732–1734. doi:10.1093/annonc/mdg491